| BRXCX | MDIHX | BRXCX / MDIHX | |
| Total Expense Ratio | 1.52 | 1.08 | 141% |
| Annual Report Gross Expense Ratio | 1.52 | 1.10 | 138% |
| Fund Existence | 10 years | 21 years | - |
| Gain YTD | 33.781 | 21.844 | 155% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 44.2B | 5% |
| Annual Yield % from dividends | 2.07 | 1.84 | 113% |
| Returns for 1 year | 33.05 | 21.09 | 157% |
| Returns for 3 years | 64.73 | 40.52 | 160% |
| Returns for 5 years | 51.80 | 24.90 | 208% |
| Returns for 10 years | 91.01 | 102.24 | 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SEVIX | 14.75 | N/A | N/A |
| SEI US Managed Volatility I (SIMT) | |||
| SCPIX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index S | |||
| JFNAX | 79.46 | -0.19 | -0.24% |
| Janus Henderson Global Life Sciences A | |||
| VSFSX | 25.51 | -0.07 | -0.27% |
| Federated Hermes MDT Small Cap Value R6 | |||
| PHPIX | 36.09 | -0.16 | -0.44% |
| ProFunds Pharmaceuticals UltraSector Inv | |||